Mark Avagliano
2022
Compensation breakdown
Non-Equity Incentive Plan | $154,382 |
---|---|
Option Awards | $380,207 |
Salary | $465,005 |
Stock Awards | $128,280 |
Other | $9,150 |
Total | $1,137,024 |
Avagliano received $465K in salary, accounting for 41% of the total pay in 2022.
Avagliano also received $154.4K in non-equity incentive plan, $380.2K in option awards, $128.3K in stock awards and $9.2K in other compensation.
Rankings
In 2022, Mark Avagliano's compensation ranked 2,783rd out of 5,736 executives tracked by ExecPay. In other words, Avagliano earned more than 51.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,783 | 52nd |
Manufacturing | 1,550 | 50th |
Chemicals And Allied Products | 719 | 49th |
Drugs | 671 | 49th |
Pharmaceutical Preparations | 485 | 50th |
Pay ratio
Mark Avagliano's Pay | $1,137,024 |
---|---|
Median Employee's Pay | $243,930 |
Pay Ratio | 5to 1 |
In 2022, the annual total compensation of Mark Avagliano was $1,137,024.
The annual total compensation of the median employee at G1 Therapeutics was $243,930.
The ratio of Mark Avagliano's pay to the pay of median employee was therefore 5 to one.
Avagliano's colleagues
We found two more compensation records of executives who worked with Mark Avagliano at G1 Therapeutics in 2022.